CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
Reveal LINQ Insertable Cardiac Monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02232022
NCT02232022N/ACompleted
CompareCT.gov

Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke

Northwell Health·interventional·Posted Sep 4, 2014·Updated Jul 30, 2019

In Brief

A clinical study evaluating Reveal LINQ Insertable Cardiac Monitor for Ischemic Stroke. Completed, enrolled 53 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine the incidence of paroxysmal atrial fibrillation (AF) in ischemic stroke patients who have a presumed known stroke etiology other than atrial fibrillation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIschemic Stroke
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 4, 2014
Enrollment StartSep 1, 2014
Primary CompletionSep 28, 2017
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 11.8 years ago

Interventions

Reveal LINQ Insertable Cardiac Monitordevice